Cell and gene therapy to cure any pathology
April 9, 2025
Revolutionizing Cancer Treatment Through CAR-T Innovation
At District 3, we're proud to showcase Modulari-T, a groundbreaking pre-seed venture in the Bio sector founded by David Cotnoir-White, Stephanie Mok, and Étienne Gagnon. This visionary team is developing transformative solutions in the biopharma space with potential to reshape cancer treatment approaches.
The Innovation: MARC Platform
Modulari-T has developed the MARC Platform, a revolutionary biochemical design for CAR-T therapies that addresses critical limitations in current treatment options. Their innovative approach:
- Overcomes significant safety concerns associated with existing therapies
- Dramatically reduces the high costs of current cancer treatments
- Enhances both efficacy and safety profiles
- Aims to position CAR-T therapy as a primary cancer treatment
- Could significantly reduce reliance on traditional chemotherapy
Strategic Growth and Development
The company is moving forward with ambitious plans for advancement and validation:
- Currently securing a $3 million investment to fuel their next phase
- Implementing a five-year roadmap focused on advancing their approach through:
- Rigorous preclinical experiments
- Comprehensive clinical trials
- Regulatory pathway development
Potential Healthcare Impact
If successful, Modulari-T's technology could fundamentally transform:
- Standard cancer treatment protocols
- Patient outcomes and quality of life
- Overall healthcare costs associated with cancer care
Contributing to Montreal's Biotech Renaissance
"BioTechnology is really picking up in Montreal right now, so there's going to be a lot of demand to build a network of founders. We're just at the beginning of a wave, and I hope it's gonna become a tidal wave."
— David Cotnoir-White, Co-founder, Modulari-T
Pioneering the Future of Cancer Treatment
Modulari-T exemplifies how District 3's ecosystem supports ventures at the cutting edge of biomedical innovation. By developing next-generation cell and gene therapies, they're working to create more effective, accessible cancer treatments while contributing to Montreal's emergence as a biotech hub. Their work demonstrates the tremendous potential of combining scientific excellence with entrepreneurial vision to address one of healthcare's most significant challenges.
We’re surrounded by inspiring people, all driven by a passion to make a difference. Meet the founders, from local to global, whose projects are creating meaningful change.
all stories
